A mechanistic model of in vitro plasma activation to evaluate therapeutic kallikrein-kinin system inhibitors
Fig 6
Model simulation comparison of BK generation in healthy and HAE plasma in the presence of 100 μg/ml DXS.
Model simulation comparison of BK generation in healthy and HAE plasma in the presence of 100 μg/ml DXS.